New Myelodysplastic Syndromes Study Results Reported from Icahn School of Medicine at Mount Sinai (Phase 1b Trial of Irak 1/4 Inhibition for Low-Risk Myelodysplastic Syndrome Refractory/Resistant to Prior Therapies: A Trial in Progress)

Media coverage

• Title	New Myelodysplastic Syndromes Study Results Reported from Icahn School of Medicine at Mount Sinai (Phase 1b Trial of Irak 1/4 Inhibition for Low-Risk Myelodysplastic Syndrome Refractory/Resistant to Prior Therapies: A Trial in Progress)
  Media name/outlet	Clinical Trials Daily
  Country/Territory	United States
  Date	18/12/23
  Persons	Lewis Silverman